Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.

Robinson S, Bowe T, Harris AH.

J Subst Abuse Treat. 2013 Nov-Dec;45(5):475-7. doi: 10.1016/j.jsat.2013.06.009. Epub 2013 Aug 9.

2.

Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.

Harris AH, Ellerbe L, Reeder RN, Bowe T, Gordon AJ, Hagedorn H, Oliva E, Lembke A, Kivlahan D, Trafton JA.

Psychol Serv. 2013 Nov;10(4):410-9. doi: 10.1037/a0030949. Epub 2013 Jan 28.

PMID:
23356858
3.

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

Baser O, Chalk M, Rawson R, Gastfriend DR.

Am J Manag Care. 2011 Jun;17 Suppl 8:S222-34.

PMID:
21761948
4.
5.

Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.

Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF; PREDICT Study Team.

Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012. Epub 2012 Dec 12.

PMID:
23231446
6.

New pharmacotherapies for alcohol dependence.

Graham R, Wodak AD, Whelan G.

Med J Aust. 2002 Jul 15;177(2):103-7. Review.

PMID:
12098353
7.
8.

Comparison of healthcare utilization among patients treated with alcoholism medications.

Mark TL, Montejano LB, Kranzler HR, Chalk M, Gastfriend DR.

Am J Manag Care. 2010;16(12):879-88.

9.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
10.

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.

Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T.

Alcohol Alcohol. 2001 Sep-Oct;36(5):419-25. Erratum in: Alcohol Alcohol 2002 Jan-Feb;37(1):105.

PMID:
11524308
12.

[The pharmacologic treatment of the alcohol dependence].

Castro LA, Baltieri DA.

Rev Bras Psiquiatr. 2004 May;26 Suppl 1:S43-6. Epub 2005 Jan 4. Portuguese.

13.

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.

Kranzler HR, Van Kirk J.

Alcohol Clin Exp Res. 2001 Sep;25(9):1335-41.

PMID:
11584154
14.

Current pharmacotherapies of alcoholism: a U.S. perspective.

Anton RF, Swift RM.

Am J Addict. 2003;12 Suppl 1:S53-68. Review.

PMID:
14972780
15.

New developments in the pharmacotherapy of alcohol dependence.

Myrick H, Brady KT, Malcolm R.

Am J Addict. 2001;10 Suppl:3-15. Review.

PMID:
11268820
16.

[Acamprosate and naltrexone: similar efficacy for relapse].

Saitz R.

Rev Med Suisse. 2014 Dec 17;10(455):2437. French. No abstract available.

PMID:
25752019
17.

Trends in the adoption of medications for alcohol dependence.

Ducharme LJ, Knudsen HK, Roman PM.

J Clin Psychopharmacol. 2006 Dec;26 Suppl 1:S13-9. Review.

PMID:
17114950
18.

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

Snyder JL, Bowers TG.

Am J Drug Alcohol Abuse. 2008;34(4):449-61. doi: 10.1080/00952990802082198.

PMID:
18584575
19.

Pharmacotherapy for Adults with Alcohol Use Disorder.

Salisbury-Afshar E.

Am Fam Physician. 2016 Jul 15;94(2):155-7. No abstract available.

20.

Recent advances in the pharmacotherapy of alcoholism.

Myrick H, Anton R.

Curr Psychiatry Rep. 2004 Oct;6(5):332-8. Review.

PMID:
15355755

Supplemental Content

Support Center